Molecular Pathology, Diagnostics, and Therapeutics of Nephropathy
Language English Country Switzerland Media electronic
Document type Editorial
PubMed
36555648
PubMed Central
PMC9786760
DOI
10.3390/ijms232416006
PII: ijms232416006
Knihovny.cz E-resources
- MeSH
- Renal Insufficiency, Chronic * diagnosis genetics therapy MeSH
- Kidney pathology MeSH
- Humans MeSH
- Pathology, Molecular MeSH
- Nephrology * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Editorial MeSH
Years of standing still have ended, and the field of nephrology has seen a plethora of clinical trials, changing the therapeutic landscape of chronic kidney disease (CKD) and immune-mediated kidney disease management [...].
Cambridge University Hospitals Addenbrooke's Hospital Hills Road Cambridge CB2 0QQ UK
Department of Medicine University of Cambridge Trinity Ln Cambridge CB2 1TN UK
See more in PubMed
Van Daalen E.E., Wester Trejo M.A.C., Göçeroğlu A., Ferrario F., Joh K., Noël L.H., Ogawa Y., Wilhelmus S., Ball M.J., Honsova E., et al. Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis. Clin. J. Am. Soc. Nephrol. 2020;15:1103–1111. doi: 10.2215/CJN.14561119. PubMed DOI PMC
Kronbichler A., Jayne D.R.W. ANCA Renal Risk Score: Is prediction of end-stage renal disease at baseline possible? Kidney Int. 2018;94:1045–1047. doi: 10.1016/j.kint.2018.10.001. PubMed DOI
Malvar A., Alberton V., Lococo B., Ferrari M., Delgado P., Nagaraja H.N., Rovin B.H. Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis. Kidney Int. 2020;97:156–162. doi: 10.1016/j.kint.2019.07.018. PubMed DOI
Bernardo-Bermejo S., Sánchez-López E., Tan L., Benito-Martínez S., Jiang Z., Castro-Puyana M., Lucio-Cazaña F.J., Marina M.L. Exploratory Metabolomic Analysis Based on Reversed-Phase Liquid Chromatography-Mass Spectrometry to Study an In Vitro Model of Hypoxia-Induced Metabolic Alterations in HK-2 Cells. Int. J. Mol. Sci. 2021;22:7399. doi: 10.3390/ijms22147399. PubMed DOI PMC
Casili G., Ardizzone A., Basilotta R., Lanza M., Filippone A., Paterniti I., Esposito E., Campolo M. The Protective Role of Prolyl Oligopeptidase (POP) Inhibition in Kidney Injury Induced by Renal Ischemia-Reperfusion. Int. J. Mol. Sci. 2021;22:1886. doi: 10.3390/ijms222111886. PubMed DOI PMC
Hwang S.H., Lee Y.M., Choi Y., Son H.E., Ryu J.Y., Na K.Y., Chin H.J., Jeon N.L., Kim S. Role of Human Primary Renal Fibroblast in TGF-β1-Mediated Fibrosis-Mimicking Devices. Int. J. Mol. Sci. 2021;22:758. doi: 10.3390/ijms221910758. PubMed DOI PMC
Sörensen-Zender I., Rong S., Haller H., Schmitt R. The Therapeutic Potential of Zinc-Alpha2-Glycoprotein (AZGP1) in Fibrotic Kidney Disease. Int. J. Mol. Sci. 2022;23:646. doi: 10.3390/ijms23020646. PubMed DOI PMC
Frydlova J., Zednikova I., Satrapova V., Pazourkova E., Santorova S., Hruskova Z., Tesar V., Vokurka M., Prikryl P., Korabecna M. Analysis of microRNAs in Small Urinary Extracellular Vesicles and Their Potential Roles in Pathogenesis of Renal ANCA-Associated Vasculitis. Int. J. Mol. Sci. 2022;23:4344. doi: 10.3390/ijms23084344. PubMed DOI PMC
Leierer J., Perco P., Hofer B., Eder S., Dzien A., Kerschbaum J., Rudnicki M., Mayer G. Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease. Int. J. Mol. Sci. 2021;22:6885. doi: 10.3390/ijms22136885. PubMed DOI PMC
Van Thiel B.S., van der Linden J., Ridwan Y., Garrelds I.M., Vermeij M., Clahsen-van Groningen M.C., Qadri F., Alenina N., Bader M., Roks A.J.M., et al. In Vivo Renin Activity Imaging in the Kidney of Progeroid. Int. J. Mol. Sci. 2021;22:2433. doi: 10.3390/ijms222212433. PubMed DOI PMC
Evgeniou M., Sacnun J.M., Kratochwill K., Perco P. A Meta-Analysis of Human Transcriptomics Data in the Context of Peritoneal Dialysis Identifies Novel Receptor-Ligand Interactions as Potential Therapeutic Targets. Int. J. Mol. Sci. 2021;22:3277. doi: 10.3390/ijms222413277. PubMed DOI PMC
